AMOBIOTIC 100mg/ml Dry Syrup (Drops)

Amoxycillin 100 mg / ml



Amobiotic® Dry syrup 100 mg/ml, each ml syrup contains : Amoxicillin trihydrate equivalent with Amoxicillin 100 mg.



Amobiotic® contains Amoxicillin trihydrate (equivalent to Amoxicillin) as its active ingredient, available as dry syrup 100 mg/ml, 125 mg/5 ml and 250 mg/5 ml and caplet 500 mg.



  • Upper respiratory tract infections e.g., tonsillitis, sinusitis and otitis media.
  • Lower respiratory tract infections e.g., acute and chronic bronchitis, lobar and bronchopneumoniae.
  • Genitourinary tract infections e.g., cystitis, urethritis, pyelonephritis, septic abortion, and puerperal sepsis.
  • Skin and soft tissue infections.
  • Gonorrhea disease caused by susceptible microorganism to gonorrhoae (non penicilinase produced).
  • Bone infection.



  • Adult and children with body weight > 20 kg : 250 – 500 mg every 8 hours.
  • Children with body weight < 20 kg : 20 – 40 mg/kgBW daily in divided doses every 8 hours.
  • Forpatientswithrenal impairment, it may be necessary to reduce the total daily dosage. In patientswho receivedperitonial dialysis, the recommendedmaximumdose of500mga day.
  • Gonococcus urethritis : Amoxicillin 3 g as a single dose.
  • Children > 8 kg should be given dry syrup.

Preparation of Amobiotic® Dry syrup 100 mg/ml :

Add 8 ml drinking water to the bottle. Shake well until evenly suspended. Keep suspension in tightly closed container. Use this suspension within 7 days. Shake well before use.



Amoxicillin is a Penicillin and should not be given to patients with a history of hypersensitivity to beta-lactam antibiotics (e.g., Penicillins, Cephalosporins).



  • Before initiating therapy with Amoxicillin, careful inquiry should be made concerning previous hypersensitivity reactions to Penicillin or Cephalosporin.
  • Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on Penicillin therapy.
  • If an allergic reaction occurs, Amoxicillin should be discontinued and appropriate therapy instituted.
  • Pseudomembranous colitis has been reported with nearly all antibacterial agents, including Amoxicillin.
  • Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of Clostridia.
  • This drug should be used during pregnancy only if clearly needed.
  • Caution should be exercised when Amoxicillin is administered to a nursing woman because Penicillin have been shown to be excreted in breast milk.
  • Prolonged use or high dose may also occasionally result in overgrowth of non-susceptible organisms (usually involving Enterobacterium, Pseudomonas, aureus, Candida) especially in the gastrointestinal tractus, the drug should be discontinued.
  • Caution should be taken for patient with lymphatic leukemia, because of sensitivity to rash that caused by Ampicillin.
  • Close clinical observation of blood, renal and liver function in prolonged treatment of Amoxicillin.
  • Urine and serum level of Amoxicillin should be monitor in patients with impaired renal functions. Dose should be adjusted.
  • Should not be given for meningitis or joint infection Amoxicillin do not passed cerebrospinal or sinovial barrier.
  • Prolonged use can lead to the growth of resistant organisms.
  • Rarely, prothrombin time extension occurs in joint use with anticoagulants. If necessary adjust the anticoagulant dose.



Amobiotic® Dry syrup 100 mg/ml                                 Box, bottle @ 10 ml

Reg. No. DKL7802344338A1





Keep suspension in tight closed container. Use this suspension within 7 days in temperature below 30ºC. Shake well before use.




Manufactured by :


Sidoarjo – Indonesia